Are the effects of rheumatoid arthritis continuing to hold you back?
Learn more about the EXPLORE research study of an injectable investigational drug for adults with difficult-to-treat rheumatoid arthritis (RA).
Rheumatoid arthritis (RA) is a long-lasting autoimmune disease in which the immune system mistakenly attacks the lining of the joints, causing pain, swelling, and stiffness. RA most commonly affects the joints of the hands and feet, although it can affect other parts of the body. Women are affected more frequently than men; RA usually develops in middle age.
Although therapies are available to help manage the symptoms and slow down the disease, some people fail to respond to treatment and continue to experience active symptoms. These people are considered to have “difficult to treat RA.” If you are one of the many people with difficult-to-treat RA, you know how frustrating it is.
This website gives information about the EXPLORE research study, in which doctors and researchers want to learn more about the safety and effectiveness of an investigational treatment given to adults with difficult-to-treat RA.
Click on the button to see if you qualify
About Research Studies
Participating in a research study is different from receiving standard medical care, which is intended to treat a condition or disease. The purpose of a research study is to collect information about an investigational treatment.
If you participate in a research study, you will be evaluated by study doctors and nurses on a regular basis during your participation.
Using the information collected in research studies, study doctors and regulatory health agencies can determine if an investigational treatment could one day be made available to the public.
By participating in the EXPLORE research study, you could help advance research for difficult-to-treat RA.